Trial Profile
Research of molecular basis of delayed asexual parasite clearance times in treatment of Plasmodium falciparum malaria with dihydroartemisinin-piperaquine in Yunnan and neighboring areas of other countries
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- 04 Sep 2017 New trial record